期刊文献+

200例缺血性脑卒中门诊患者二级预防的现况调查 被引量:8

A study on secondary prevention of 200 patients with ischemic stroke
下载PDF
导出
摘要 目的了解目前缺血性脑卒中患者二级预防的现况。方法对200名脑卒中门诊患者的高血压、糖尿病、高血脂、心房纤颤等高危因素的知晓情况、服药情况及控制情况进行询问和检查。着重了解抗血栓药,特别是阿司匹林的服用情况和未服原因。结果规律服用阿司匹林者占被调查者的28.5%,高血压的控制率仅为43.3%,有10%的被调查者从未检测过血糖;被调查患者的戒烟率为27.3%;戒酒率为39.7%。结论目前我国脑卒中患者二级预防的现状不容乐观。 Objective The aim of the study is to determine the rate of compliance with secondary stroke prevention and to identify the reasons for poor compliance. Methods Of the consecutive patients admitted to the neurological department of hospital between Jul 3,2009 and Aug 29,2009,200 patients with ischemic stroke were involved in this investigation and were finally evaluated. The proportion of patients compliant with prevention of risk factors ( hypertension, diabetes, hyperlipidemia) was evaluated. Results In the 200 patients, the rate of antithrombotic drug compliance was 28.5%. Of the patients with hypertension,diabetes,only 76.7% and 59. 1% were still treated for their respective risk factors. Conclusion Compliance with secondary prevention in patients with isehemic stroke is poor in the setting of our study. Doctors should attach importance to secondary prevention and provide stroke patients detailed guidelines for the use of preventive drugs.
出处 《中国医学创新》 CAS 2011年第26期136-138,共3页 Medical Innovation of China
关键词 缺血性脑卒中 二级预防 现况调查 Ischemic stroke Secondary prevention Risk factors
  • 相关文献

参考文献5

二级参考文献58

  • 1Sacco RL, Adams R, Albers G, et al; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37:577 -617.
  • 2Bhatt DL, Fox KA, Hacke W, et al; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med, 2006, 354:1706 - 1717.
  • 3Diener HC, Bogousslavsky J, Brass LM, et al; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004, 364:331 -337.
  • 4ESPRIT Study Group, Halkes PH, van Gijn J,Kappelle LJ, et al. AAspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet, 2006, 367:1665 - 1673.
  • 5Lindgren A, Husted S, Staaf G, et al. Dipyridamole and headache: a pilot study of initial dose titration. J Neurol Sci, 2004, 223:179 - 184.
  • 6Chang YJ, Ryu SJ, Lee TH. Dose titration to reduce dipyridamolerelated headache. Cerebrovasc Dis, 2006, 22:258 -262.
  • 7Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med, 2004, 164: 722 - 732.
  • 8Goldstein LB, Adams R, Alberts MJ, et al; American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 2006, 37:1583 -1633.
  • 9Pandey DK, Gorelick PB. Should statin agents be administered to all patients with ischemic stroke? Arch Neurol, 2005,62:23 -24.
  • 10Amarenco P, Bogousslavsky J, Callahan A 3rd, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006, 355 : 549 - 559.

共引文献288

同被引文献53

  • 1徐成斌.调脂治疗在缺血性脑卒中治疗中的地位及作用[J].临床药物治疗杂志,2005,3(6):1-4. 被引量:3
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 3Sillesen H, Zivin JA, Welch KM, et al.High-dose atorvastatin afterstroke or transient isehemie attack[J].N Eng J Med, 2006, 355(6) : 549.
  • 4Li C,Hedblad B,Rosvall M,et al.Stroke incidence,recurrence,and case-fatality in relation to socioeconomic position:A population based study of middle-aged swedish men and women[J].Stroke,2008,39(8):2191-2196.
  • 5Progress Collaborative Group.Randomised trial of a perindoprilbased blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack[J].Lancet,2001,358(9287):1033-1041.
  • 6van Gijn J.The progress trial:preventing st rokes by lowering blood pressure in patients with cerebral ischemia.Emerging therapies:critique of an important advance[J].Stroke,2002,33(1):391-320.
  • 7Lawes CM,Bennett DA,Feiqin VL,et al.Blood pressure and stroke.an overview of published reviews[J].Stroke,2004,35(4):1024.
  • 8孙慧.高血压患者服药依从性的调查分析及对策[J].中外健康文摘,2011,40(8):118-119.
  • 9Touzé E,Coste J,Voicu M,et al.Importance of in-hospitalinitiation of therapies and therapeutic inertia in secondary stroke prevention:implementation of prevention after a cerebrovascular event(IMPACT)study[J].Stroke,2008,39(6):1834-1843.
  • 10Hackam DG.Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings:Yes[J].Stroke,2009,40(9):3159-3161.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部